RT Journal Article
SR Electronic
T1 629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26<sup>hi</sup> T cell in patients with resectable stage III melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A718
OP A718
DO 10.1136/jitc-2023-SITC2023.0629
VO 11
IS Suppl 1
A1 Ruffin, Ayana T
A1 Olson, Brian
A1 Mallow, Crystal
A1 Reilly, Christine
A1 Hammons, Jacklyn
A1 Kim, Jayden
A1 Burns, Brian
A1 Harutyunyan, Agnes
A1 Evans, Elizabeth
A1 Fisher, Terrence
A1 Zauderer, Maurice
A1 Delman, Keith A
A1 Yushak, Melinda
A1 Mokhtari, Ali
A1 Parker, Douglas
A1 Kudchadkar, Ragini
A1 Paulos, Chrystal M
A1 Lesinski, Gregory B
A1 Lowe, Michael C
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A718.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.